Copanlisib (Aliqopa) for relapsed follicular lymphoma

Med Lett Drugs Ther. 2018 Apr 23;60(1545):e74-e75.
No abstract available

Keywords: Rituxan; Treanda; Zydelig; adverse effects; bendamustine; dosage; drug interactions; efficacy; idelalisib; pregnancy; rituximab; safety.

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / economics
  • Drug Costs
  • Drug Interactions
  • Humans
  • Lymphoma, Follicular / drug therapy*
  • Lymphoma, Follicular / pathology
  • Phosphatidylinositol 3-Kinase / metabolism
  • Phosphoinositide-3 Kinase Inhibitors*
  • Protein Kinase Inhibitors / administration & dosage*
  • Protein Kinase Inhibitors / adverse effects
  • Protein Kinase Inhibitors / economics
  • Pyrimidines / administration & dosage*
  • Pyrimidines / adverse effects
  • Pyrimidines / economics
  • Quinazolines / administration & dosage*
  • Quinazolines / adverse effects
  • Quinazolines / economics
  • Recurrence
  • Signal Transduction / drug effects
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Quinazolines
  • Phosphatidylinositol 3-Kinase
  • copanlisib